Literature DB >> 8411337

In vitro expression of the human cytomegalovirus DNA polymerase gene: effects of sequence alterations on enzyme activity.

L B Ye1, E S Huang.   

Abstract

Genomic DNA of the Towne strain human cytomegalovirus polymerase (pol) gene (4.4-kb RsrII-NcoI segment of the EcoRI J fragment) was cloned into plasmids containing either the T3 or the T7 promoter for in vitro transcription-translation studies. The translation efficiency of unmodified pol cRNA was poor in this system and could not be improved by capping. However, the efficiency could be enhanced by replacing the leader sequence with a 40-bp AT-rich sequence derived from an alfalfa mosaic virus, R4. pol cRNA directed the synthesis of a 140-kDa polypeptide in a rabbit reticulocyte translation system. The in vitro-translated wild-type enzyme possessed significant polymerization activity which could be stimulated by salt as could that of the authentic enzyme purified from virus-infected cells. To study the critical domains of this enzyme, nine mutations were introduced into the pol gene around the conserved domains of eukaryotic polymerase by oligonucleotide-directed mutagenesis. Two constructs with mutations at amino acid residues 323 to 325 (M32QS) and 725 to 726 (M72II) remained active, with partial loss of enzyme activity, while the enzyme activities of other mutants with alterations at four domains located around amino acid residues 729 to 730 (M73HN), 804 to 807 (M80 and DE80), 910 to 913 (M91 and DE91), and 962 to 964 (M96 and DE96) were abolished. DNA template and triphosphate binding assays indicated that the mutation at 804 to 807 (conserved region III) lost the ability to bind DNA template, and four mutants, M73HN (within conserved region II), M80 (in region III), M91 (in region I), and M96 (around region V [962 to 964; amino acid sequence KKR]), failed to bind deoxyribonucleoside triphosphate. These data suggest that conserved region III is essential for DNA template binding, while residues between conserved region II and V (725 to 964) are involved in triphosphate binding.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8411337      PMCID: PMC238068     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains.

Authors:  R M Stenberg; J Fortney; S W Barlow; B P Magrane; J A Nelson; P Ghazal
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

2.  Site-specific mutagenesis of a highly conserved region of the herpes simplex virus type 1 DNA polymerase gene.

Authors:  D I Dorsky; C S Crumpacker
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

3.  The herpes simplex virus type 1 DNA polymerase gene: site of phosphonoacetic acid resistance mutation in strain Angelotti is highly conserved.

Authors:  C W Knopf
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

4.  Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition.

Authors:  J S Gibbs; H C Chiou; K F Bastow; Y C Cheng; D M Coen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

5.  The essential 65-kilodalton DNA-binding protein of herpes simplex virus stimulates the virus-encoded DNA polymerase.

Authors:  M L Gallo; D I Dorsky; C S Crumpacker; D S Parris
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

6.  A conserved 3'----5' exonuclease active site in prokaryotic and eukaryotic DNA polymerases.

Authors:  A Bernad; L Blanco; J M Lázaro; G Martín; M Salas
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

7.  Genetic and crystallographic studies of the 3',5'-exonucleolytic site of DNA polymerase I.

Authors:  V Derbyshire; P S Freemont; M R Sanderson; L Beese; J M Friedman; C M Joyce; T A Steitz
Journal:  Science       Date:  1988-04-08       Impact factor: 47.728

8.  Expression of herpes simplex virus type 1 DNA polymerase gene by in vitro translation and effects of gene deletions on activity.

Authors:  D I Dorsky; C S Crumpacker
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

9.  Enhanced translation of chimaeric messenger RNAs containing a plant viral untranslated leader sequence.

Authors:  S A Jobling; L Gehrke
Journal:  Nature       Date:  1987 Feb 12-18       Impact factor: 49.962

10.  Human DNA polymerase alpha gene expression is cell proliferation dependent and its primary structure is similar to both prokaryotic and eukaryotic replicative DNA polymerases.

Authors:  S W Wong; A F Wahl; P M Yuan; N Arai; B E Pearson; K Arai; D Korn; M W Hunkapiller; T S Wang
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more
  10 in total

1.  Characterization of the DNA- and dNTP-binding activities of the human cytomegalovirus DNA polymerase catalytic subunit UL54.

Authors:  Frédéric Picard-Jean; Isabelle Bougie; Martin Bisaillon
Journal:  Biochem J       Date:  2007-11-01       Impact factor: 3.857

Review 2.  Human cytomegalovirus resistance to antiviral drugs.

Authors:  C Gilbert; G Boivin
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Cloning, expression, and functional characterization of the equine herpesvirus 1 DNA polymerase and its accessory subunit.

Authors:  Arianna Loregian; Alessandro Case; Enrico Cancellotti; Carlo Valente; Howard S Marsden; Giorgio Palù
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Role of helix P of the human cytomegalovirus DNA polymerase in resistance and hypersusceptibility to the antiviral drug foscarnet.

Authors:  Egor P Tchesnokov; Christian Gilbert; Guy Boivin; Matthias Götte
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Differentiation between polymorphisms and resistance-associated mutations in human cytomegalovirus DNA polymerase.

Authors:  Meike Chevillotte; Ina Ersing; Thomas Mertens; Jens von Einem
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

6.  Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.

Authors:  Gillian M Scott; Adriana Weinberg; William D Rawlinson; Sunwen Chou
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

7.  Identification of mutation sites of a temperature-sensitive mutant of HCMV DNA polymerase activity.

Authors:  S Ihara; M Takekoshi; N Mori; S Sakuma; J Hashimoto; Y Watanabe
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.

Authors:  T Cihlar; M D Fuller; J M Cherrington
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Four of eleven loci required for transient complementation of human cytomegalovirus DNA replication cooperate to activate expression of replication genes.

Authors:  A C Iskenderian; L Huang; A Reilly; R M Stenberg; D G Anders
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Fluorescence-based assay for phenotypic characterization of human cytomegalovirus polymerase mutations regarding drug susceptibility and viral replicative fitness.

Authors:  Meike Chevillotte; Axel Schubert; Thomas Mertens; Jens von Einem
Journal:  Antimicrob Agents Chemother       Date:  2009-06-22       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.